Infective endocarditis caused by highly penicillin-resistant Streptococcus pneumoniae: successful treatment with cefuzonam, ampicillin and imipenem.
Okumura
A
A
Department of Pediatrics, Anjo Kosei Hospital, Aichi, Japan.
Ito
K
K
Kondo
M
M
Takahashi
H
H
Hayakawa
F
F
Ogawa
A
A
Kuno
K
K
D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D015296:Ceftizoxime / Q000031:analogs & derivatives / Q000627:therapeutic use; D002675:Child, Preschool; D004697:Endocarditis, Bacterial / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D008297:Male; D008826:Microbial Sensitivity Tests; D010403:Penicillin Resistance; D011008:Pneumococcal Infections / Q000188:drug therapy* / Q000503:physiopathology; D013296:Streptococcus pneumoniae / Q000187:drug effects
D000900:Anti-Bacterial Agents; D015378:Imipenem; D000667:Ampicillin; C049934:cefuzonam; D015296:Ceftizoxime